Physician profile
Rohit Dhingra
NPI 1366892077
$4,466.79
in general payments reported to CMS, 2019-2025
9 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.50 · 2020: $145 · 2021: $242 · 2022: $384 · 2023: $765 · 2024: $1,591 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,395 · Travel and Lodging: $285 · Grant: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,395.00 |
| Travel and Lodging | $285.16 |
| Grant | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,549.11 | 2024-2025 | Endoflip, Barrx |
| Boston Scientific Corporation | $1,493.21 | 2021-2025 | Apollo Esg System, Axios, Apollo Esg Nxt System |
| Apollo Endosurgery US INC | $606.45 | 2023 | Overstitch Endoscopic Suturing System |
| Janssen Biotech, INC. | $287.53 | 2019-2024 | Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.26 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $120.61 | 2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $104.24 | 2020-2022 | |
| Abbvie INC. | $96.55 | 2019-2025 | |
| Erbe USA INC | $40.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Dhingra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.